Clinical Trial

Transient Pseudohypoaldosteronism Affecting Children With Urinary Tract Malformation

Study acronym: TPHA
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated April 1, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Pseudohypoaldosteronism is a pathology affecting children under 6 months of age, little known but which can have serious consequences. There are no real figures on the prevalence of this pathology in France. The exact pathophysiology is not known and the management is not currently codified. This is why it is interesting to study this pathology and its treatment on a national scale in order to think about the best possible treatment, as well as to raise awareness of this pathology among different health professionals.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06905600
Lead Sponsor University Hospital, Strasbourg, France
Conditions Pseudohypoaldosteronism
Enrollment 50 participants
Start Date 2024-01-31
Primary Completion 2025-12 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-01